Annual EBITDA
-$6.61 M
-$1.17 M-21.44%
01 March 2024
Summary:
Virax Biolabs Group Limited annual earnings before interest, taxes, depreciation & amortization is currently -$6.61 million, with the most recent change of -$1.17 million (-21.44%) on 01 March 2024. During the last 3 years, it has fallen by -$5.96 million (-925.78%). VRAX annual EBITDA is now -925.78% below its all-time high of -$644.30 thousand, reached on 31 March 2021.VRAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRAX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.4% | - | - |
| 3 y3 years | -925.8% | - | - |
| 5 y5 years | - | - | - |
VRAX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -925.8% | at low | ||||
| 5 y | 5 years | -925.8% | at low | ||||
| alltime | all time | -925.8% | at low |
Virax Biolabs Group Limited EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$6.61 M(+21.4%) | - | - |
| Mar 2023 | -$5.44 M(+213.8%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | -$1.73 M(+169.2%) | - | - |
| Mar 2021 | -$644.30 K(-0.7%) | - | - |
| Mar 2020 | -$648.80 K | - | - |
FAQ
- What is Virax Biolabs Group Limited annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual EBITDA year-on-year change?
What is Virax Biolabs Group Limited annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of VRAX is -$6.61 M
What is the all time high annual EBITDA for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual earnings before interest, taxes, depreciation & amortization is -$644.30 K
What is Virax Biolabs Group Limited annual EBITDA year-on-year change?
Over the past year, VRAX annual earnings before interest, taxes, depreciation & amortization has changed by -$1.17 M (-21.44%)